| 臺大學術典藏 |
2021-11-04T08:48:09Z |
Lipids and lipoproteins in health and disease: Focus on targeting atherosclerosis
|
Lee C.-K.; CHE-WEI LIAO; Meng S.-W.; Wu W.-K.; Chiang J.-Y.; Wu M.-S. |
| 臺大學術典藏 |
2021-10-18T06:30:01Z |
Carbon dioxide insufflation can significantly reduce toilet use after colonoscopy: A double-blind randomized controlled trial
|
Hsu W.-F.; Hu W.-H.; YEN-NIEN CHEN; Lai H.-H.; Chen M.-K.; Chang L.-C.; Tu C.-H.; Chou C.-K.; Wang H.-P.; Wu M.-S.; Chiu H.-M. |
| 臺大學術典藏 |
2021-10-18T06:30:00Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; Fang Y.-J.; Chen C.-C.; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; YEN-NIEN CHEN; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-10-18T06:30:00Z |
Systematic review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection
|
Chen M.-J.; Chen C.-C.; YEN-NIEN CHEN; Chen C.-C.; Fang Y.-J.; Lin J.-T.; Wu M.-S.; Liou J.-M.; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-10-18T06:29:59Z |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
|
Liou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; Chen C.-C.; Fang Y.-J.; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; Wu M.-S.; Liou J.-M.; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chen C.-C.; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; Cheng T.-Y.; Tseng P.-H.; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; YEN-NIEN CHEN; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-10-18T06:29:59Z |
From germ theory to germ therapy
|
Chen C.-C.; YEN-NIEN CHEN; Liou J.-M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-10-18T06:29:58Z |
Application of Helicobacter pylori stool antigen test to survey the updated prevalence of Helicobacter pylori infection in Taiwan
|
Chen M.-J.; Fang Y.-J.; Wu M.-S.; Chen C.-C.; YEN-NIEN CHEN; Yu C.-C.; Kuo C.-C.; Chiu M.-C.; Hu W.-H.; Tsai M.-H.; Hsieh C.-L.; Chen H.-H.; Bair M.-J.; Liou J.-M.; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-10-18T06:29:58Z |
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial
|
Liou J.-M.; Chen C.-C.; Chang C.-M.; Fang Y.-J.; Bair M.-J.; Chen P.-Y.; Chang C.-Y.; Hsu Y.-C.; Chen M.-J.; Chen C.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chen C.-Y.; Hsu W.-F.; YEN-NIEN CHEN; Wu J.-Y.; Lin J.-T.; Lu T.-P.; Chuang E.Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-10-18T06:29:57Z |
Risk stratification for gastric cancer after Helicobacter pylori eradication: A population-based study on Matsu Islands
|
Chiang T.-H.; Maeda M.; Yamada H.; Chan C.-C.; Chen S.L.-S.; Chiu S.Y.-H.; YEN-NIEN CHEN; Chou Y.-H.; Shieh C.-F.; Liu C.-Y.; Chiu H.-M.; Chiang H.; Shun C.-T.; Lin M.-W.; Wu M.-S.; Lin J.-T.; Chen H.-H.; Ushijima T.; Graham D.Y.; Lee Y.-C. |
| 臺大學術典藏 |
2021-10-06T08:04:50Z |
Norepinephrine administration is associated with higher mortality in dialysis requiring acute kidney injury patients with septic shock
|
Chen Y.-Y.; Wu V.-C.; Huang W.-C.; Yeh Y.-C.; Wu M.-S.; Huang C.-C.; Wu K.-D.; Fang J.-T.; Wu C.-J.; Wu V.-C.; Lai T.-S.; Lin Y.-F.; I-JUNG TSAI; Lai C.-F.; Huang T.-M.; Chu T.-S.; Chen Y.-M.; Chang Y.-H.; Yeh Y.-C.; Lai C.-H.; Tseng L.-J.; Wu K.-D.; Wang J.-J.; Chen C.-Y.; Shiao C.-C.; Wang W.-J.; Lin J.-H.; Wu C.-H.; Wu C.-J.; Lu K.-C.; Kan W.-C.; Huang C.-C.; Chou C.-Y.; Yang Y.-F.; Tsai J.-P.; Hu F.-C.; Lee C.-T.; Chen J.-B.; Lee C.-H.; Lee W.-C.; Li L.-C.; Chen T.-C.; Lin H.Y.-H.; Chen Y.-C.; Lee C.-C.; Sun C.-Y.; Pan H.-C.; Chang M.-Y.; Jenq C.-C.; Lin C.-Y.; Chang C.-H.; Tsai T.-Y.; Chen C.-M.; Lin E.-T.; Wu C.-J.; Lin C.-J.; Wu P.-C.; Kuo F.-C.; Weng C.-J.; Chen L.-K.; Lin S.-L.; Yang W.-S.; Hsu W.-D.; Leu J.-G.; Chang J.-T.; Liou H.-H.; Hsu K.-H.; Wu M.-J.; Huang C.-T.; You Z.-H.; Chang C.-F.; Chen T.-W.; Chen H.-H.; Chang F.-C.; Lin Y.-C.; Wu M.-S.; Kao C.-C.; Hung S.-C.; Kuo K.-L.; Wu C.-H.; Tarng D.-C.; Chen J.-Y.; Yang C.-Y.; Lee K.-H.; Ko S.-W.; The NSARF, CAKS Group |
| 臺大學術典藏 |
2021-09-17T06:04:06Z |
Alternative Complement Pathway Is Activated and Associated with Galactose-Deficient IgA1 Antibody in IgA Nephropathy Patients
|
Chiu Y.-L.; Lin W.-C.; Shu K.-H.; Fang Y.-W.; Chang F.-C.; Chou Y.-H.; Wu C.-F.; Chiang W.-C.; SHUEI-LIONG LIN; Chen Y.-M.; Wu M.-S. |
| 臺大學術典藏 |
2021-09-15T06:19:22Z |
Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: A long-term cohort study on Matsu Islands
|
Chiang T.-H.; Chang W.-J.; Chen S.L.-S.; Yen A.M.-F.; Fann J.C.-Y.; Chiu S.Y.-H.; Chen Y.-R.; Chuang S.-L.; Shieh C.-F.; Liu C.-Y.; Chiu H.-M.; Chiang H.; Shun C.-T.; Lin M.-W.; Wu M.-S.; Lin J.-T.; CHANG-CHUAN CHAN; Graham D.Y.; Chen H.-H.; Lee Y.-C. |
| 臺大學術典藏 |
2021-09-15T06:19:21Z |
Community-Based Gastric Cancer Screening Coupled With a National Colorectal Cancer Screening Program: Baseline Results
|
Lee Y.-C.; Chiang T.-H.; Chiu H.-M.; Wu M.-S.; Yeh Y.-P.; Hsiu-Hsi Chen T.; Li-Sheng Chen S.; Ming-Fang Yen A.; Ching-Yuan Fann J.; Yueh-Hsia Chiu S.; Hsu C.-Y.; Chuang S.-L.; Chou K.-C.; Su W.-W.; Chen S.-T.; Liao C.-S.; Lin Y.-M.; Chang H.-C.; Hu T.-H.; Fang Y.-J.; CHANG-CHUAN CHAN; Collaborators of the Taiwan Community-Based Integrated Screening Group |
| 臺大學術典藏 |
2021-09-15T06:19:21Z |
Risk stratification for gastric cancer after Helicobacter pylori eradication: A population-based study on Matsu Islands
|
Chiang T.-H.; Maeda M.; Yamada H.; CHANG-CHUAN CHAN; Chen S.L.-S.; Chiu S.Y.-H.; Chen Y.-N.; Chou Y.-H.; Shieh C.-F.; Liu C.-Y.; Chiu H.-M.; Chiang H.; Shun C.-T.; Lin M.-W.; Wu M.-S.; Lin J.-T.; Chen H.-H.; Ushijima T.; Graham D.Y.; Lee Y.-C. |
| 臺大學術典藏 |
2021-09-04T06:12:19Z |
Recent advances in clinical application of gut hormones
|
Tseng P.-H.; Wu M.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:11:10Z |
Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative Patients
|
Hsu Y.-C.; Mo L.-R.; Chang C.-Y.; Wu M.-S.; JIA-HORNG KAO; Wang W.-L.; Yang T.-H.; Wang C.-S.; Chiang M.-F.; Chen C.-C.; Fang Y.-J.; Hung H.-W.; Wu C.-Y.; Lin J.-T. |
| 臺大學術典藏 |
2021-09-04T06:11:00Z |
Serum viral load at the virological relapse predicts subsequent clinical flares in chronic hepatitis B patients off entecavir therapy
|
Hsu Y.-C.; Mo L.-R.; Chang C.-Y.; Wu M.-S.; Yang T.-H.; JIA-HORNG KAO; Chen C.-C.; Tseng C.-H.; Tai C.-M.; Lin C.-W.; Wu C.-Y.; Lin J.-T. |
| 臺大學術典藏 |
2021-09-04T05:17:12Z |
Time-varying serum gradient of hepatitis B surface antigen predicts risk of relapses after off-NA therapy
|
Chien N.-H.; Huang Y.-T.; Wu C.-Y.; Chang C.-Y.; Wu M.-S.; JIA-HORNG KAO; Mo L.-R.; Tai C.-M.; Lin C.-W.; Yang T.-H.; Lin J.-T.; Hsu Y.-C. |
| 臺大學術典藏 |
2021-09-04T05:17:03Z |
Quantification of serum hepatitis B core antibody to predict off-entecavir relapse in patients with chronic hepatitis B
|
Tseng C.-H.; Hsu Y.-C.; Chang C.-Y.; Tseng T.-C.; Wu M.-S.; Lin J.-T.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-02T00:03:49Z |
Stock Movement Prediction That Integrates Heterogeneous Data Sources Using Dilated Causal Convolution Networks with Attention
|
Daiya D;Wu M.-S;Lin C.; Daiya D; Wu M.-S; Lin C.; CHE LIN |
| 臺大學術典藏 |
2021-09-01T02:02:41Z |
Infrequent hMSH2 mutations in sporadic gastric adenocarcinoma with microsatellite instability
|
Wu M.-S.; Sheu J.-C.; Shun C.-T.; Lee W.-J.; Wang J.-T.; Wang T.-H.; ANN-LII CHENG; Lin J.-T. |
| 臺大學術典藏 |
2021-09-01T02:02:34Z |
Hypermethylation of the p16 gene in sporadic T3NOMO stage colorectal cancers: Association with DNA replication error and shorter survival
|
Liang J.-T.; Chang K.-J.; Chen J.-C.; Lee C.-C.; Cheng Y.-M.; Hsu H.-C.; Wu M.-S.; Wang S.-M.; Lin J.-T.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:25Z |
Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age
|
Liang J.T.; Huang K.C.; ANN-LII CHENG; Jeng Y.M.; Wu M.S.; Wang S.M. |
| 臺大學術典藏 |
2021-09-01T02:02:20Z |
Promoter polymorphisms of tumor necrosis factor-α are associated with risk of gastric mucosa-associated lymphoid tissue lymphoma
|
Wu M.-S.; Chen L.-T.; Shun C.-T.; Huang S.-P.; Chiu H.-M.; Wang H.-P.; Lin M.-T.; ANN-LII CHENG; Lin J.-T. |
| 臺大學術典藏 |
2021-09-01T02:02:19Z |
Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas
|
Kuo S.-H.; Chen L.-T.; Yeh K.-H.; Wu M.-S.; Hsu H.-C.; Yeh P.-Y.; Mao T.-L.; Chen C.-L.; Doong S.-L.; Lin J.-T.; ANN-LII CHENG |
